Congenital Cytomegalovirus, Valganciclovir, Antiviral, Hearing Loss, Sensorineural, Infant, Toddler, Audiology
HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial
HIV, adolescents, dolutegravir, short cycle therapy, young people, randomised controlled trial
HIV, children, adolescents, dolutegravir, weight-gain, body fat percentage, lipid profile, glycaemia